Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability
Titel:
Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability
Auteur:
Lévi, Francis Karaboué, Abdoulaye Gorden, Lee Innominato, Pasquale Fabio Saffroy, Raphael Giacchetti, Sylvie Hauteville, Dominique Guettier, Catherine Adam, René Bouchahda, Mohamed